← Leaderboards
Alysson R. Muotri
University Of California, San Diego
$33,814,580
Attributed
$50,794,454
Total exposure
25
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,794,454 · 25
By mechanism
R01$35,310,965 · 13
R44$5,126,146 · 3
U19$2,524,410 · 1
RF1$2,319,456 · 1
DP2$2,317,500 · 1
R21$1,278,875 · 3
Top collaborators
- Lilia M Iakoucheva17 shared
- John Robert Yates10 shared
- Fabio Cohen Tucci6 shared
- Steven H Olson5 shared
- Alexey V Terskikh5 shared
- Hollis T Cline4 shared
- Alon Goren4 shared
- Paul W. Burridge2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Karen L Pierce$25,516,195
- Lilia M Iakoucheva$8,653,469
- Richard L Gallo$35,320,517
- George L Sen$13,431,495
- Nathan Enoch Lewis$6,510,737
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsBrainCellsInduced Pluripotent Stem CellMolecularPhenotypeAutism Spectrum DisorderGenesGeneticBaseOrganoidsPathway InteractionsExperimental StudyLinkProteinsSynaptogenesisAffectMutationMouse ModelInsightCell TypeNerve Stem CellPlayTechnology
Grant awards (89)
A new brain organoid model for NeuroHIV and the impact of opioids$784,742
R01 · FY2025 · DA · contact PI
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$781,258
R01 · FY2025 · MH · contact PI
Establishment of a causal link between AD and L1 retrotransposons$766,077
R01 · FY2025 · AG · contact PI
Proteogenetics of Autism Spectrum Disorders$683,101
R01 · FY2025 · MH
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models$604,748
R01 · FY2025 · ES
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease$442,942
R01 · FY2025 · NS · contact PI
Impact of prenatal inflammation on developing human brain$346,647
R01 · FY2025 · HD · contact PI
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model$335,750
R01 · FY2025 · MH · contact PI
Nextgen AD Models, Endotypes, and Screening$2,319,456
RF1 · FY2024 · AG
A new brain organoid model for NeuroHIV and the impact of opioids$786,533
R01 · FY2024 · DA · contact PI
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$784,231
R01 · FY2024 · MH · contact PI
Establishment of a causal link between AD and L1 retrotransposons$783,212
R01 · FY2024 · AG · contact PI
Proteogenetics of Autism Spectrum Disorders$684,218
R01 · FY2024 · MH
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models$602,132
R01 · FY2024 · ES
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease$429,655
R01 · FY2024 · NS · contact PI
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model$395,000
R01 · FY2024 · MH · contact PI
Impact of prenatal inflammation on developing human brain$343,181
R01 · FY2024 · HD · contact PI
A new brain organoid model for NeuroHIV and the impact of opioids$788,284
R01 · FY2023 · DA · contact PI
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$787,147
R01 · FY2023 · MH · contact PI
Establishment of a causal link between AD and L1 retrotransposons$784,679
R01 · FY2023 · AG · contact PI
Brain pathology and function in a chronic mouse model of ZIKV transmission$654,901
R01 · FY2023 · NS
Proteogenetics of Autism Spectrum Disorders$610,597
R01 · FY2023 · MH
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models$605,693
R01 · FY2023 · ES
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease$442,942
R01 · FY2023 · NS · contact PI
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model$395,000
R01 · FY2023 · MH · contact PI
Impact of prenatal inflammation on developing human brain$346,647
R01 · FY2023 · HD · contact PI
Effects of acetaminophen on prenatal brain development: an organoid model$197,500
R21 · FY2023 · HD
Novel therapy for Fragile X syndrome$1,157,216
R44 · FY2022 · MH
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$789,998
R01 · FY2022 · MH · contact PI
A new brain organoid model for NeuroHIV and the impact of opioids$789,998
R01 · FY2022 · DA · contact PI
Establishment of a causal link between AD and L1 retrotransposons$786,116
R01 · FY2022 · AG · contact PI
HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs$735,163
R44 · FY2022 · GM
Cortical organoid models to study autism-associated 16p.11.2.CNV$706,333
R56 · FY2022 · MH
Brain pathology and function in a chronic mouse model of ZIKV transmission$655,064
R01 · FY2022 · NS
Proteogenetics of Autism Spectrum Disorders$637,920
R01 · FY2022 · MH
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models$606,887
R01 · FY2022 · ES
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease$442,942
R01 · FY2022 · NS · contact PI
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model$395,000
R01 · FY2022 · MH · contact PI
Impact of prenatal inflammation on developing human brain$346,647
R01 · FY2022 · HD · contact PI
Effects of acetaminophen on prenatal brain development: an organoid model$237,000
R21 · FY2022 · HD
Novel therapy for Fragile X syndrome$998,958
R44 · FY2021 · MH
HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs$760,359
R44 · FY2021 · GM
Proteogenetics of Autism Spectrum Disorders$672,469
R01 · FY2021 · MH
Brain pathology and function in a chronic mouse model of ZIKV transmission$655,075
R01 · FY2021 · NS
iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening$634,006
R44 · FY2021 · AG
The impact of hiPSC-derived microglia in human brain development in health and disease$442,942
R01 · FY2021 · NS · contact PI
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model$394,479
R01 · FY2021 · MH · contact PI
Administrative supplement for Novel therapy for Fragile X syndrome$50,000
R44 · FY2021 · MH
iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening$790,444
R44 · FY2020 · AG
Brain pathology and function in a chronic mouse model of ZIKV transmission$654,787
R01 · FY2020 · NS
Proteogenetics of Autism Spectrum Disorders$608,199
R01 · FY2020 · MH
Evaluating the effect of splicing mutations on isoform networks in autism$520,041
R01 · FY2020 · MH
Integrative functional genomic study of pathways impacted by recurrent autism CNV$485,555
R01 · FY2020 · MH
Brain pathology and function in a chronic mouse model of ZIKV transmission$678,490
R01 · FY2019 · NS
Proteogenetics of Autism Spectrum Disorders$608,199
R01 · FY2019 · MH
Reproducible protocols for robust cortical neuron and astroglial differentiation$554,873
U19 · FY2019 · MH · contact PI
Evaluating the effect of splicing mutations on isoform networks in autism$519,915
R01 · FY2019 · MH
Integrative functional genomic study of pathways impacted by recurrent autism CNV$485,555
R01 · FY2019 · MH
Proteogenetics of Autism Spectrum Disorders$608,199
R01 · FY2018 · MH
Reproducible protocols for robust cortical neuron and astroglial differentiation$554,873
U19 · FY2018 · MH · contact PI
Evaluating the effect of splicing mutations on isoform networks in autism$519,794
R01 · FY2018 · MH
Integrative functional genomic study of pathways impacted by recurrent autism CNV$506,480
R01 · FY2018 · MH
Novel therapy for Fragile X syndrome$317,514
R41 · FY2018 · MH
Proteogenetics of Autism Spectrum Disorders$608,199
R01 · FY2017 · MH
Evaluating the effect of splicing mutations on isoform networks in autism$519,676
R01 · FY2017 · MH
Integrative functional genomic study of pathways impacted by recurrent autism CNV$513,455
R01 · FY2017 · MH
Reproducible protocols for robust cortical neuron and astroglial differentiation$453,211
U19 · FY2017 · MH · contact PI
Novel therapy for Fragile X syndrome$399,938
R41 · FY2017 · MH
Novel therapy for Fragile X syndrome$117,346
R41 · FY2017 · MH
Integrative functional genomic study of pathways impacted by recurrent autism CNV$586,005
R01 · FY2016 · MH
Proteogenetics of Autism Spectrum Disorders$583,992
R01 · FY2016 · MH
Reproducible protocols for robust cortical neuron and astroglial differentiation$453,211
U19 · FY2016 · MH · contact PI
Evaluating the effect of splicing mutations on isoform networks in autism$420,427
R01 · FY2016 · MH
A human neurodevelopmental model for Williams syndrome$375,971
R56 · FY2016 · MH · contact PI
Exosome-mediated cell-cell signaling in Rett Syndrome$308,750
R01 · FY2016 · MH
A chimeric brain model to study human neurological diseases$232,500
R21 · FY2016 · MH · contact PI
Reproducible protocols for robust cortical neuron and astroglial differentiation$508,242
U19 · FY2015 · MH · contact PI
The Impact of L1retrotransposition in the nervous system$375,210
R01 · FY2015 · MH · contact PI
Exosome-mediated cell-cell signaling in Rett Syndrome$353,125
R01 · FY2015 · MH
A chimeric brain model to study human neurological diseases$193,750
R21 · FY2015 · MH · contact PI
The Impact of L1retrotransposition in the nervous system$376,327
R01 · FY2014 · MH · contact PI
Exosome-mediated cell-cell signaling in Rett Syndrome$353,125
R01 · FY2014 · MH
Exosome-mediated cell-cell signaling in Rett Syndrome$414,250
R01 · FY2013 · MH
The Impact of L1retrotransposition in the nervous system$362,249
R01 · FY2013 · MH · contact PI
Modeling anorexia nervosa with human pluripotent stem cells$186,000
R21 · FY2013 · MH · contact PI
The Impact of L1retrotransposition in the nervous system$378,171
R01 · FY2012 · MH · contact PI
Modeling anorexia nervosa with human pluripotent stem cells$232,125
R21 · FY2012 · MH · contact PI
The Impact of L1retrotransposition in the nervous system$377,936
R01 · FY2011 · MH · contact PI
Modeling autism with human pluripotent cells$2,317,500
DP2 · FY2009 · OD · contact PI